Concepedia

Publication | Closed Access

The cost‐effectiveness of NAT for HIV, HCV, and HBV in whole‐blood donations

DOI

266

Citations

21

References

2003

Year

Brian R. Jackson, M.P. Busch, Susan L. Stramer, James P. AuBuchon
Transfusion

Abstract

The cost-effectiveness of whole-blood NAT is poor. The testing cost would need to decrease significantly to bring the cost-effectiveness in line with most other accepted medical practices.

References

YearCitations

Page 1